Displaying items by tag: Alzheimers

In a significant move to enhance dementia care, thousands in the UK will participate in a trial to test blood for dementia, led by University College London and Oxford University. This five-year study aims to facilitate early access to care, support, and emerging drug treatments. About 5,000 volunteers will be involved in researching blood tests for Alzheimer's and other dementias. Currently, diagnostic methods like PET brain scans or spinal lumbar punctures, which detect brain proteins linked to Alzheimer's, are costly and underutilised. This trial explores more accessible blood tests, potentially a more economical and straightforward approach. The aim of the study (which focuses on various forms of dementia, including Alzheimer's) is to improve diagnosis rates, particularly in early stages or mild memory issues. This trial holds promise, especially with the development of new drugs like Lecanemab and Donanemab, which potentially slow the progression of the disease. Alzheimer’s Research UK has highlighted the critical need for advances in dementia diagnosis, mirroring progress in other diseases.